Status:
WITHDRAWN
Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates
Lead Sponsor:
Samsung Medical Center
Conditions:
Lung Cancer
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is to evaluate the feasibility of aspiration samples for mutational analysis in patients with a non-small cell lung cancer (NSCLC).
Detailed Description
The investigators will compare results of mutational analysis from a core needle biopsy and fine needle aspiration.
Eligibility Criteria
Inclusion
- primary tumor or a metastatic lung lesion requested for mutational analysis
Exclusion
- a) lesions located adjacent to the large central bronchi or vessels
- b) peribronchovascular lesions with prominent internal CT air-bronchograms, which were considered difficult to be avoided by needle pass
- c) lesions in patient with severe respiratory compromise
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01482572
Start Date
January 1 2012
End Date
November 1 2015
Last Update
November 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea